Sinovac Biotech Ltd
NASDAQ:SVA
Sinovac Biotech Ltd
Interest Income Expense
Sinovac Biotech Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sinovac Biotech Ltd
NASDAQ:SVA
|
Interest Income Expense
$189.6m
|
CAGR 3-Years
426%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Interest Income Expense
-¥59.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Interest Income Expense
¥445.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
84%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Interest Income Expense
¥217.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
134%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Interest Income Expense
-¥33.6m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Interest Income Expense
¥100.8m
|
CAGR 3-Years
126%
|
CAGR 5-Years
96%
|
CAGR 10-Years
N/A
|
See Also
What is Sinovac Biotech Ltd's Interest Income Expense?
Interest Income Expense
189.6m
USD
Based on the financial report for Dec 31, 2022, Sinovac Biotech Ltd's Interest Income Expense amounts to 189.6m USD.
What is Sinovac Biotech Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
426%
Over the last year, the Interest Income Expense growth was 90%. The average annual Interest Income Expense growth rates for Sinovac Biotech Ltd have been 426% over the past three years .